Status:
COMPLETED
The Effect of Midazolam Premedication on Copeptine Concentration in Blood
Lead Sponsor:
Medical University of Warsaw
Conditions:
Preanesthetic Medication
Copeptin
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The study aim is to assess whether premedication with midazolam prior to surgery affects copeptin concentration in blood.
Eligibility Criteria
Inclusion
- Patients scheduled for elective surgery
- Patients with no chronić illness and considered ASA 1 by anesthesiologist
- Patients with mild and controlled chronic illness considered ASA 2 by anesthesiologist
Exclusion
- Patient refusal
- Chronic illness requiring intense treatment or uncontrolled illness (ASA 3 or more)
Key Trial Info
Start Date :
April 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03474939
Start Date
April 3 2017
End Date
March 1 2019
Last Update
April 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I Department of Anesthesiology and Intensive Care Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland, 02-005